Express Pharma
DECEMBER 26, 2024
Despite advances in biologic therapies for severe asthma, significant unmet needs in asthma management remain, specifically with T-helper cell type 2 (T2)-low asthma, a subtype lacking typical inflammatory biomarkers. T2-low asthma presents unique challenges due to the absence of eosinophils and immunoglobulin E (IgE), which complicates both diagnosis and treatment.
Drug Patent Watch
DECEMBER 26, 2024
The biopharmaceutical sector has made significant strides in developing and delivering effective drugs to improve health and combat diseases. However, the high cost of prescription drugs remains a significant barrier to access for many patients. One key solution to this issue lies in the role of generic drugs, which are significantly cheaper than branded products and can help reduce the financial burden on patients and the healthcare system.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
DECEMBER 26, 2024
Akums Group has announced a strategic long-term agreement with a global pharma company (Akums has not revealed details of the partner yet) to manufacture and supply pharmaceutical formulations in the European market. Under this collaboration, Akums Group will produce and supply multiple SKUs of oral liquid formulations, which the partner company will market across various European countries.
PharmaTech
DECEMBER 26, 2024
Challenges that can prevent sponsors realizing the full potential of managed access programs can be overcome by embracing a just-in-time manufacturing strategy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
DECEMBER 26, 2024
Mankind Pharma and Innovent Biologics have announced a partnership to exclusively license and commercialise sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region. Cancer has become a major health concern in India, with its burden projected to reach 29.8 million DALYs by 2025, according to The National Cancer Registry Progr
PharmaTech
DECEMBER 26, 2024
The launch of Roche's cobas mass spectrometry solution will bring fully automated mass spec analysis to the clinical lab.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Compounding Pharmacy of America
DECEMBER 26, 2024
Discover how compounding pharmacies provide custom solutions for seniors, improving medication adherence, reducing side effects, and enhancing quality of life. The post How Compounding Pharmacies Help Seniors Easily Manage Prescriptions appeared first on Compounding Pharmacy of America.
PharmExec
DECEMBER 26, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Compounding Pharmacy of America
DECEMBER 26, 2024
Learn how dental compounding services provide personalized medication for oral health. Explore solutions for pain relief, dry sockets, and other dental needs. The post A Guide to Dental Compounding Services appeared first on Compounding Pharmacy of America.
PharmaTech
DECEMBER 26, 2024
Pointing to the continued circulation and evolution of COVID-19, WHO published a statement on the COVID-19 vaccine antigen composition to respond to variants of the virus.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Script
DECEMBER 26, 2024
Is your organization suffering from increased employee turnover? Our team at Rx relief explains how to reduce turnover & retain talent.
Pharmaceutical Commerce
DECEMBER 26, 2024
The top five episodes of our podcast in the year 2024, highlighted.
PharmExec
DECEMBER 26, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
DECEMBER 26, 2024
AstraZeneca and Daiichi Sankyo have withdrawn marketing authorisation application in the EU voluntarily, intended for datopotamab deruxtecan.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
PharmExec
DECEMBER 26, 2024
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the biggest misconceptions about fertility that he sees circulating on social media and work he does to correct and prevent them.
Pharmaceutical Technology
DECEMBER 26, 2024
Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Tachycardia (Tachyarrhythmias).
Pharmacy Times
DECEMBER 26, 2024
Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
Pharmaceutical Technology
DECEMBER 26, 2024
Allergen for Grass Pollen Allergy is under clinical development by Roxall Medizin and currently in Phase II for Grass Pollen Allergy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
DECEMBER 26, 2024
High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.
Pharmaceutical Technology
DECEMBER 26, 2024
Darigabat is under clinical development by Cerevel Therapeutics and currently in Phase II for Seizures.
Pharmacy Times
DECEMBER 26, 2024
Yi Lin, MD, PhD, highlights the importance of achieving MRD negativity in multiple myeloma, CAR T-cell therapy outcomes, and the critical role of pharmacists in patient care.
Pharmaceutical Technology
DECEMBER 26, 2024
Nelivaptan is under clinical development by HMNC and currently in Phase II for Major Depressive Disorder.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
STAT
DECEMBER 26, 2024
Genetic sequences of H5N1 bird flu viruses collected from a person in Louisiana who became severely ill show signs of development of several mutations thought to affect the virus’ ability to attach to cells in the upper airways of humans, the Centers for Disease Control and Prevention reported on Thursday. One of the mutations was also seen in a virus sample taken from a teenager in British Columbia who was in critical condition in a Vancouver hospital for weeks after contracting H5N1.
Pharmaceutical Technology
DECEMBER 26, 2024
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Sarcomas.
STAT
DECEMBER 26, 2024
The global medical community encountered a highly contagious aerosolized pathogen with no known treatment when the SARS-CoV 2-virus triggered the Covid-19 global pandemic nearly five years ago. Fortunately, Covid responded to treatment with convalescent plasma while other therapies and vaccinations were under development. Today, the H5N1 avian flu virus, currently lurking in birds and cows, is perhaps only a few mutations away from a potentially similar widespread and deadly outbreak in hu
Pharmaceutical Technology
DECEMBER 26, 2024
Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Osteosarcoma.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
DECEMBER 26, 2024
Corona Remedies announced that it has pledged 25 crore towards Corporate Social Responsibility (CSR) initiatives over the next five years. As part of its 20th anniversary celebrations, the company donated to 20 NGOs across Gujarat and Maharashtra. Beneficiaries included organisations such as Jivan Dhara Old Age Home in Ahmedabad, Manav Jyot Public Charitable Trust in Mumbai, and Shree Pragnachakshu Mahila Seva Kunj in Surendranagar.
Pharmaceutical Technology
DECEMBER 26, 2024
Tricaprilin is under clinical development by Cerecin and currently in Phase II for Infantile Spasm (West Syndrome).
Big Molecule Watch
DECEMBER 26, 2024
The European Medicines Agencys (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars. The CHMP recommended approval of four biosimilars developed by Celltrion: (1) AVTOZVMA (tocilizumab), for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, CAR-T cell-induced severe or life-threatening cytokine release syndrome and COVID-19; (2) EYDENZELT (aflibercept)
Pharmaceutical Technology
DECEMBER 26, 2024
KGYY-15 is under clinical development by Op-T-Mune and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes).
Pharmaceutical Business Review
DECEMBER 26, 2024
A human monoclonal antibody, BAT2206 is currently undergoing regulatory review with several health authorities, including the China National Medical Products Administration (NMPA), the US Food and Drug Administration (FDA), and the European Medicines Agency (EMA). Tabuk Pharmaceuticals CEO Ismail Shehada said: “We are excited to announce our partnership with Bio-Thera that will enable us to deliver unique and specialised health solutions aimed at enhancing the well-being of people inSaudi
Expert insights. Personalized for you.
105 
Let's personalize your content